US Tech 100

18,064.80

0.02%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
AMEX
Gentium Spa Ads (GNT)
Gentium Spa Ads (GNT) News

GNT

Gentium Spa (GNT)

Gentium Spa Ads

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:GNT

1

Date	Time	Source	Headline	Symbol	Company
05/16/2006	7:00AM	Business Wire	Gentium Begins Trading on NASDAQ; New Ticker Symbol: GENT	AMEX:GNT	Gentium Spa Ads
05/05/2006	7:42AM	Business Wire	Gentium to Trade on NASDAQ National Market	AMEX:GNT	Gentium Spa Ads
04/13/2006	5:00AM	Business Wire	Gentium Reports 2005 Financial Results; Provides Financial and Clinical Update	AMEX:GNT	Gentium Spa Ads
03/28/2006	7:00AM	Business Wire	Gentium Receives First IRB Approval to Begin U.S. Phase III Trial with Defibrotide to Treat Veno-Occlusive Disease with Multipl	AMEX:GNT	Gentium Spa Ads
02/02/2006	7:00AM	Business Wire	Gentium to Present at Angiogenesis in Cancer and Vascular Disease Congress; Defibrotide Has Anti-Angiogenic Properties In Vitro	AMEX:GNT	Gentium Spa Ads
01/30/2006	7:00AM	Business Wire	Gentium's Defibrotide Subject of Independent Study in Japan; First Japanese Study Reports That Defibrotide Shows Success Treatin	AMEX:GNT	Gentium Spa Ads
01/20/2006	6:30AM	Business Wire	Gentium Initiates Phase II/III Pediatric Trial with Defibrotide to Prevent Veno-Occlusive Disease; European Group for Blood and	AMEX:GNT	Gentium Spa Ads
11/15/2005	6:00AM	Business Wire	Gentium Reports Third Quarter Financial Results; Provides Financial and Clinical Update	AMEX:GNT	Gentium Spa Ads
11/07/2005	9:12AM	Business Wire	Gentium to Present at Rodman & Renshaw Techvest Seventh Annual Healthcare Conference	AMEX:GNT	Gentium Spa Ads
10/17/2005	5:00AM	Business Wire	Gentium Completes $10.9 Million Private Placement	AMEX:GNT	Gentium Spa Ads
10/04/2005	8:23AM	Business Wire	Gentium Raises $10.9 Million in Private Offering; Funding to Support New Trials and Continued Development of Pipeline	AMEX:GNT	Gentium Spa Ads
09/21/2005	5:00AM	Business Wire	Gentium S.p.A. Announces Initiation of Independent Phase I/II Study of Defibrotide to treat Multiple Myeloma	AMEX:GNT	Gentium Spa Ads
09/15/2005	3:00AM	Business Wire	Renowned Bone Marrow Transplantation Expert Richard E. Champlin, M.D., Joins Gentium's Scientific Advisory Board	AMEX:GNT	Gentium Spa Ads
09/07/2005	3:00AM	Business Wire	Gentium S.p.A. Announces Intention to Commence Phase III Trial Following Discussions with FDA	AMEX:GNT	Gentium Spa Ads
08/10/2005	3:00AM	Business Wire	Gentium Reports Second Quarter Financial Results, Provides Clinical Update	AMEX:GNT	Gentium Spa Ads
08/09/2005	3:00AM	Business Wire	Gentium Presented Laboratory Data at XXth Congress of International Society for Thrombosis and Haemostasis; Laboratory Data Pres	AMEX:GNT	Gentium Spa Ads
07/13/2005	3:05PM	Business Wire	Gentium S.p.A. Announces FDA Agrees Company's CMC Submission is Adequate for Commencing Phase III Clinical Trials with Defibroti	AMEX:GNT	Gentium Spa Ads
06/16/2005	5:10PM	PR Newswire (US)	American Stock Exchange Lists American Depository Shares Representing Ordinary Shares Of Gentium S.p.A	TSXV:GNT
06/16/2005	11:38AM	PR Newswire (US)	Gentium S.p.A. Announces Pricing of Initial Public Offering	TSXV:GNT